Trending Now
Business
Former Trump Campaign Official Accuses Fani Willis Of ‘Improper Relationship’ With...
Former Trump campaign official, Michael Roman, filed a motion accusing Fulton County district attorney, Fani Willis, of having an improper relationship with...
Valeant Is ‘Desert Thirsty’ For Equity
Valeant (VRX) spooked investors last week when it filed an application to raise additional capital with the securities regulator in Quebec:
Valeant sparked expectations that...
Lifestyle today
Entertainment
‘Trump Baby’ Blimp Flies In London Ahead Of Visit
Making friends and influencing people appears to be President Trump's specialty. Love him or hate him, you have to react to Trump and you...
‘Illegal’ Payments For Opioids? Et Tu Teva?
According to sources the government of Ontario is investigating whether Teva (TEVA) made "illegal" payments to stock its opioid medications:
The Ontario government is investigating...
Did Judge Harvey Bartle Seal Allergan’s Fate?
When it comes to protecting its drug patents Allergan's (AGN) management team appears to be smarter than the average bear. The company has thwarted...
SHAM! Allergan Says Mohawks Bought $14 Billion Patents With Immunity Promise
Allergan's odd patent transfer to the St. Regis Mohawk Tribe is gaining a lot of scrutiny. It sued rivals from offering generic Restasis, its...
Judge Dismisses North Dakota Opioid Suit; Endo Could Surge
Last year President Trump was highly critical of opioid drug manufacturers. He wanted to shed more light on their role in the opioid crisis....
Ignore Carl Icahn; Allergan Is 50% Overvalued
Allergan (AGN) is down about 30% Y/Y. The S&P 500 (SPY) has grown 14% over that time frame. If AGN cannot grow amid central...
General Electric Is Making Harry Markopolos Look Like A Genius
General Electric (GE) remains one of the most maligned publicly-traded companies. Last year Bernie Madoff whistleblower Harry Markopolos looked askance at GE's balance sheet....
Allergan: Is Linzess ‘Restasis 2.0’?
Friday Allergan (AGN) Forest Laboratories ( and Ironwood Pharmaceuticals (IRWD) accused Teva (TEV) of infringing upon a patent for Linzess, which treats irritable bowel...
























































































































